285 related articles for article (PubMed ID: 11461679)
21. Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay.
Beirnaert E; Willems B; Peeters M; Bouckaert A; Heyndrickx L; Zhong P; Vereecken K; Coppens S; Davis D; Ndumbe P; Janssens W; van der Groen G
J Virol Methods; 1998 Jul; 73(1):65-70. PubMed ID: 9705176
[TBL] [Abstract][Full Text] [Related]
22. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection.
Ondoa P; Willems B; Fransen K; Nkengasong J; Janssens W; Heyndrickx L; Zekeng L; Ndumbe P; Simon F; Saragosti S; Gürtler L; Peeters M; Korber B; Goudsmit J; van der Groen G
AIDS Res Hum Retroviruses; 1998 Jul; 14(11):963-72. PubMed ID: 9686642
[TBL] [Abstract][Full Text] [Related]
25. Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzee.
Vanden Haesevelde MM; Peeters M; Jannes G; Janssens W; van der Groen G; Sharp PM; Saman E
Virology; 1996 Jul; 221(2):346-50. PubMed ID: 8661445
[TBL] [Abstract][Full Text] [Related]
26. Computer analysis of the amino acid sequences in gp41 of apathogenic African green monkey (AGM) virus, less pathogenic HIV-2 and highly pathogenic SIV and HIV-1 lentiviruses.
Becker Y
Virus Genes; 1992 Nov; 6(4):319-32. PubMed ID: 1335629
[TBL] [Abstract][Full Text] [Related]
27. New STLV-3 strains and a divergent SIVmus strain identified in non-human primate bushmeat in Gabon.
Liégeois F; Boué V; Mouacha F; Butel C; Ondo BM; Pourrut X; Leroy E; Peeters M; Rouet F
Retrovirology; 2012 Mar; 9(1):28. PubMed ID: 22462797
[TBL] [Abstract][Full Text] [Related]
28. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
[TBL] [Abstract][Full Text] [Related]
29. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
[TBL] [Abstract][Full Text] [Related]
30. Antibody recognition of SIVmac envelope peptides in plasma from macaques experimentally infected with SIV/Mne.
Shafferman A; Layne A; Sadoff J; Burke DS; Morton WR; Benveniste RE
AIDS Res Hum Retroviruses; 1989 Jun; 5(3):327-36. PubMed ID: 2543433
[TBL] [Abstract][Full Text] [Related]
31. A novel simian immunodeficiency virus (SIVdrl) pol sequence from the drill monkey, Mandrillus leucophaeus.
Clewley JP; Lewis JC; Brown DW; Gadsby EL
J Virol; 1998 Dec; 72(12):10305-9. PubMed ID: 9811781
[TBL] [Abstract][Full Text] [Related]
32. Phylogeny and natural history of the primate lentiviruses, SIV and HIV.
Hirsch VM; Dapolito G; Goeken R; Campbell BJ
Curr Opin Genet Dev; 1995 Dec; 5(6):798-806. PubMed ID: 8745080
[TBL] [Abstract][Full Text] [Related]
33. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1.
Norrby E; Putkonen P; Böttiger B; Utter G; Biberfeld G
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):279-85. PubMed ID: 1712215
[TBL] [Abstract][Full Text] [Related]
34. Advantage of dimeric peptide antigens in serodiagnosis of HIV-1 infection.
Gokulan K; Tripathi SP; Rao DN
Microbiol Immunol; 1997; 41(3):215-20. PubMed ID: 9130233
[TBL] [Abstract][Full Text] [Related]
35. The use of multiple antigenic peptide (MAP) in the immunodiagnosis of human immunodeficiency virus infection.
Shin SY; Lee MK; Kim SY; Jang SY; Hahm KS
Biochem Mol Biol Int; 1997 Nov; 43(4):713-21. PubMed ID: 9385431
[TBL] [Abstract][Full Text] [Related]
36. Widely varying SIV prevalence rates in naturally infected primate species from Cameroon.
Aghokeng AF; Liu W; Bibollet-Ruche F; Loul S; Mpoudi-Ngole E; Laurent C; Mwenda JM; Langat DK; Chege GK; McClure HM; Delaporte E; Shaw GM; Hahn BH; Peeters M
Virology; 2006 Feb; 345(1):174-89. PubMed ID: 16257029
[TBL] [Abstract][Full Text] [Related]
37. Phylogenetic analysis of SIV derived from mandrill and drill.
Takemura T; Hayami M
Front Biosci; 2004 Jan; 9():513-20. PubMed ID: 14766387
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of synthetic peptides for the detection of antibodies against human immunodeficiency virus].
Lottersberger J; Salvetti JL; Tonarelli G
Rev Argent Microbiol; 2003; 35(3):149-55. PubMed ID: 14587377
[TBL] [Abstract][Full Text] [Related]
39. Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans.
Tebit DM; Nickel G; Gibson R; Rodriguez M; Hathaway NJ; Bain K; Reyes-Rodriguez AL; Ondoa P; Heeney JL; Li Y; Bongorno J; Canaday D; McDonald D; Bailey JA; Arts EJ
EBioMedicine; 2024 Feb; 100():104965. PubMed ID: 38215691
[TBL] [Abstract][Full Text] [Related]
40. Sequence of a novel simian immunodeficiency virus from a wild-caught African mandrill.
Tsujimoto H; Hasegawa A; Maki N; Fukasawa M; Miura T; Speidel S; Cooper RW; Moriyama EN; Gojobori T; Hayami M
Nature; 1989 Oct; 341(6242):539-41. PubMed ID: 2797181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
